Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Xylem Inc., a leading global water technology company, reported solid results in the third quarter of 2025.</li><li>The company demonstrated strong financial performance with notable growth across its segments and has adjusted its full-year outlook upwards due to ongoing robust demand and efficient execution of its strategic initiatives.</li><li>Positively, Xylem registered an increase in revenue across all its segments, with a marked double-digit growth in both Measurement and Control Solutions (MCS) and Water Solutions and Services (WSS).</li></ul>

Xylem Inc., a leading global water technology company, reported solid results in the third quarter of 2025.The company demonstrated strong financial performance with notable growth across its segments and has adjusted its full-year outlook upwards due to ongoing robust demand and efficient execution of its strategic initiatives.Positively, Xylem registered an increase in revenue across all its segments, with a marked double-digit growth in both Measurement and Control Solutions (MCS) and Water Solutions and Services (WSS).

Xylem Teams Up with Amazon: How Smart Water Tech Is Reshaping Global Cities!

<ul><li>Xylem reported strong results for the second quarter of 2025, showcasing broad-based organic revenue growth led by significant performance in measurement and control solutions.</li><li>The company achieved a record adjusted EBITDA margin of 21.8%, an increase of 100 basis points year-over-year, with adjusted EPS rising in the midteens.</li><li>The demand for Xylem’s products, particularly in smart metering, remains strong, prompting the company to raise its full-year revenue and EPS guidance.</li></ul>

Xylem reported strong results for the second quarter of 2025, showcasing broad-based organic revenue growth led by significant performance in measurement and control solutions.The company achieved a record adjusted EBITDA margin of 21.8%, an increase of 100 basis points year-over-year, with adjusted EPS rising in the midteens.The demand for Xylem’s products, particularly in smart metering, remains strong, prompting the company to raise its full-year revenue and EPS guidance.

Xylem Unlocks Evoqua Synergies Ahead of Schedule – Can Integration Keep Driving Growth?

<ul><li>Xylem Inc. closed the first quarter of 2025 with a performance that surpassed expectations and reaffirmed their guidance for the year.</li><li>The company reported a robust revenue increase across all segments, contributing to a 120 basis point rise in EBITDA margin and a double-digit growth in earnings per share (EPS), which hit $1.03, outpacing the guidance midpoint by $0.08.</li><li>Maintaining a backlog of $5.1 billion, Xylem showcased resilience in demand with a book-to-bill ratio exceeding one, although orders slightly dipped due to challenging comparisons in key segments.</li></ul>

Xylem Inc. closed the first quarter of 2025 with a performance that surpassed expectations and reaffirmed their guidance for the year.The company reported a robust revenue increase across all segments, contributing to a 120 basis point rise in EBITDA margin and a double-digit growth in earnings per share (EPS), which hit $1.03, outpacing the guidance midpoint by $0.08.Maintaining a backlog of $5.1 billion, Xylem showcased resilience in demand with a book-to-bill ratio exceeding one, although orders slightly dipped due to challenging comparisons in key segments.

Xylem Looking To Supercharge Growth With Targeted Acquisitions—Is The Vacom Deal Just The Start?

<ul><li>Xylem's fourth-quarter and full-year 2024 results demonstrate a robust performance, setting new benchmarks in revenue, EBITDA margins, and EPS.</li><li>Revenue increased by 6%, EBITDA margins expanded by 170 basis points, and EPS rose by double digits.</li><li>The company's operational discipline and successful integration of Evoqua, which is delivering cost synergies faster than expected, underpin these achievements.</li></ul>

Xylem's fourth-quarter and full-year 2024 results demonstrate a robust performance, setting new benchmarks in revenue, EBITDA margins, and EPS.Revenue increased by 6%, EBITDA margins expanded by 170 basis points, and EPS rose by double digits.The company's operational discipline and successful integration of Evoqua, which is delivering cost synergies faster than expected, underpin these achievements.

Xylem Inc.: An Insight Into Its Market Dynamics & Growth Potential in MCS!

<ul><li>Xylem's Third Quarter 2024 Earnings presented a mixed financial picture marked by strong profit margins and operational discipline but moderated revenue growth.</li><li>CEO Matthew Pine highlighted robust earnings and record EBITDA margins achieved during the quarter due to disciplined execution across the business and efficient integration of Evoqua, which is now ahead of schedule in cost synergies.</li><li>Baptista Research looks to evaluate the different factors that could influence the company's price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.</li></ul>

Xylem's Third Quarter 2024 Earnings presented a mixed financial picture marked by strong profit margins and operational discipline but moderated revenue growth.CEO Matthew Pine highlighted robust earnings and record EBITDA margins achieved during the quarter due to disciplined execution across the business and efficient integration of Evoqua, which is now ahead of schedule in cost synergies.Baptista Research looks to evaluate the different factors that could influence the company's price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

Xylem Inc.: How Its Recent Operational Excellence & Synergy Capture From Evoqua Integration Driving our Optimism! - Major Drivers

United States

Xylem, Inc. is a designer, manufacturer, equipment and service provider for water and wastewater applications addressing the full-cycle of water from collection, distribution, and use to the return of water to the environment. The Company's products include water and wastewater pumps, treatment and testing equipment, industrial pumps, valves, heat exchangers, and dispensing equipment.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Xylem Inc (XYL US)

Xylem Teams Up with Amazon: How Smart Water Tech Is Reshaping Global Cities!

Xylem Inc., a leading global water technology company, reported solid results in the third quarter of 2025. The company demonstrated strong...

Baptista Research

Xylem Unlocks Evoqua Synergies Ahead of Schedule – Can Integration Keep Driving Growth?

Xylem reported strong results for the second quarter of 2025, showcasing broad-based organic revenue growth led by significant performance in...

Baptista Research

Xylem Looking To Supercharge Growth With Targeted Acquisitions—Is The Vacom Deal Just The Start?

Xylem Inc. closed the first quarter of 2025 with a performance that surpassed expectations and reaffirmed their guidance for the year. The company...

Baptista Research

Xylem Inc.: An Insight Into Its Market Dynamics & Growth Potential in MCS!

Xylem's fourth-quarter and full-year 2024 results demonstrate a robust performance, setting new benchmarks in revenue, EBITDA margins, and...

Baptista Research

Xylem Inc.: How Its Recent Operational Excellence & Synergy Capture From Evoqua Integration Driving our Optimism! - Major Drivers

Xylem's Third Quarter 2024 Earnings presented a mixed financial picture marked by strong profit margins and operational discipline but moderated...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)